PL377683A1 - System terapeutyczny zawierający amoksycylinę i kwas klawulanowy - Google Patents
System terapeutyczny zawierający amoksycylinę i kwas klawulanowyInfo
- Publication number
- PL377683A1 PL377683A1 PL377683A PL37768304A PL377683A1 PL 377683 A1 PL377683 A1 PL 377683A1 PL 377683 A PL377683 A PL 377683A PL 37768304 A PL37768304 A PL 37768304A PL 377683 A1 PL377683 A1 PL 377683A1
- Authority
- PL
- Poland
- Prior art keywords
- amoxicillin
- clavulanic acid
- therapeutic system
- dosage
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200300044A SI21401A (sl) | 2003-02-21 | 2003-02-21 | Terapevtski sistem |
SI200300245A SI21601A (sl) | 2003-09-24 | 2003-09-24 | Terapevtski sistem |
Publications (2)
Publication Number | Publication Date |
---|---|
PL377683A1 true PL377683A1 (pl) | 2006-02-06 |
PL213804B1 PL213804B1 (pl) | 2013-05-31 |
Family
ID=32911559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377683A PL213804B1 (pl) | 2003-02-21 | 2004-02-20 | Uklad terapeutyczny do podawania amoksycyliny i kwasu klawulanowego, oraz kapsulka unoszaca sie na powierzchni cieczy |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060121106A1 (pl) |
EP (1) | EP1596841B1 (pl) |
AT (1) | ATE410152T1 (pl) |
BR (1) | BRPI0407438A (pl) |
CA (1) | CA2516327C (pl) |
DE (1) | DE602004016963D1 (pl) |
EA (1) | EA011215B1 (pl) |
MX (1) | MXPA05008843A (pl) |
PL (1) | PL213804B1 (pl) |
SI (1) | SI1596841T1 (pl) |
WO (1) | WO2004073695A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7527807B2 (en) | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
EP1681050A1 (en) * | 2005-01-13 | 2006-07-19 | Strides Arcolab Limited | Dispersible sustained release pharmaceutical compositions |
NZ580951A (en) | 2005-04-29 | 2011-06-30 | Cubist Pharm Inc | Therapeutic compositions |
US8357394B2 (en) * | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
CA2635378C (en) * | 2005-12-08 | 2015-06-16 | Advancis Pharmaceutical Corporation | Pharmaceutical compositions and methods for improved bacterial eradication |
EP2063862A2 (en) | 2006-09-04 | 2009-06-03 | Matrix Laboratories Ltd | Pharmaceutical formulation for use in hiv therapy |
CN104224737A (zh) * | 2010-02-24 | 2014-12-24 | 硕腾有限责任公司 | 兽医组合物 |
KR20140117523A (ko) * | 2012-01-10 | 2014-10-07 | 마이클 스펙터 | 아목시실린 및 클라불란산 칼륨의 소아용 경구 현탁 제형 및 이를 사용하기 위한 방법 |
CA2864088C (en) * | 2012-02-08 | 2020-04-28 | Supernus Pharmaceuticals, Inc. | Modified release formulations of viloxazine |
US20140279169A1 (en) * | 2013-03-15 | 2014-09-18 | Toyota Motor Sales, U.S.A., Inc. | Method for generating vehicle repair estimate reports based on predictive estimating |
EP3125873B1 (en) | 2014-04-04 | 2020-06-03 | Pharmaquest International Center, LLC | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5512411B2 (pl) * | 1974-03-12 | 1980-04-02 | ||
US4083956A (en) * | 1976-04-29 | 1978-04-11 | The Procter & Gamble Company | Anhydrous antiperspirant creams |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
GB9407386D0 (en) * | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
JP2959423B2 (ja) * | 1994-12-01 | 1999-10-06 | シオノギクオリカプス株式会社 | カプセル用皮膜組成物 |
AU2001292185A1 (en) * | 2000-10-12 | 2002-04-22 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
-
2004
- 2004-02-20 PL PL377683A patent/PL213804B1/pl unknown
- 2004-02-20 US US10/545,111 patent/US20060121106A1/en not_active Abandoned
- 2004-02-20 MX MXPA05008843A patent/MXPA05008843A/es not_active IP Right Cessation
- 2004-02-20 DE DE602004016963T patent/DE602004016963D1/de not_active Expired - Lifetime
- 2004-02-20 BR BR0407438-6A patent/BRPI0407438A/pt not_active IP Right Cessation
- 2004-02-20 AT AT04713281T patent/ATE410152T1/de not_active IP Right Cessation
- 2004-02-20 SI SI200430999T patent/SI1596841T1/sl unknown
- 2004-02-20 WO PCT/SI2004/000010 patent/WO2004073695A1/en active Search and Examination
- 2004-02-20 EA EA200501223A patent/EA011215B1/ru not_active IP Right Cessation
- 2004-02-20 EP EP04713281A patent/EP1596841B1/en not_active Expired - Lifetime
- 2004-02-20 CA CA2516327A patent/CA2516327C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0407438A (pt) | 2006-02-07 |
WO2004073695A1 (en) | 2004-09-02 |
DE602004016963D1 (en) | 2008-11-20 |
PL213804B1 (pl) | 2013-05-31 |
ATE410152T1 (de) | 2008-10-15 |
SI1596841T1 (sl) | 2009-06-30 |
EP1596841A1 (en) | 2005-11-23 |
CA2516327C (en) | 2012-04-17 |
EA200501223A1 (ru) | 2006-04-28 |
CA2516327A1 (en) | 2004-09-02 |
US20060121106A1 (en) | 2006-06-08 |
EP1596841B1 (en) | 2008-10-08 |
MXPA05008843A (es) | 2005-10-18 |
EA011215B1 (ru) | 2009-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076605A1 (en) | Formulations | |
TWI265812B (en) | Pharmaceutical safety dosage forms | |
TW200633730A (en) | Oral disintegrating dosage forms | |
IL149147A0 (en) | Use of oxcarbazepine for the manufacture of oral dosage form medicament | |
WO2008069941A3 (en) | Modified release ibuprofen solid oral dosage form | |
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors | |
MXPA05002942A (es) | Forma de dosificacion oral de liberacion modificada. | |
WO2006108692A3 (en) | Dosage form for oral administration of a vitamin | |
ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
TN2010000135A1 (en) | Galenical formulations of organic compounds | |
HRP20041092A2 (en) | New pharmaceutical compositions containing filbanserin polymorph a | |
PL377683A1 (pl) | System terapeutyczny zawierający amoksycylinę i kwas klawulanowy | |
PT1425005E (pt) | Composicao farmaceutica que compreende lumiracoxib | |
BR0314129A (pt) | Formulações de liberação modificadas de oxcarbazepina e derivados destas | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
DE60124144D1 (de) | Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte | |
BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
WO2004024128A3 (en) | Modified release ketoprofen dosage form | |
WO2004033484A3 (en) | Use of stable glutamine derivatives to improve drug absorption | |
EA200400691A1 (ru) | Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства | |
MX2007003994A (es) | Composici??n farmaceutica para el tratamiento de xeroftalmia y xerostomia. | |
AU2003202550A1 (en) | Pharmaceutical formulations with modified release | |
BR0311209A (pt) | Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete |